Osteoprotegerin and rank ligand expression in prostate cancer

Urology

Volumn 57, Issue 4, 2001, Pages 611-616

  Brown, Julie M ^a,b   Corey, Eva ^a,b   Lee, Zandra D ^a,b   True, Lawrence D ^a,b   Yun, Theodore J ^a,b   Tondravi, Mehrdad ^a,b   Vessella, Robert L ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL RECEPTOR; CYTOKINE; GLYCOPROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

AGED; ARTICLE; BONE TUMOR; CHEMISTRY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; BONE NEOPLASMS; CARRIER PROTEINS; CYTOKINES; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOPROTEGERIN; PROSTATE; PROSTATIC NEOPLASMS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER;

EID: 0035319658     PISSN: None     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)01122-5     Document Type: Article

References (16)

1. N.W Clarke J McClure N.J.R George Morphometric evidence for bone resorption and replacement in prostate cancer Br J Urol 68 1991 74 80
2. H Yasuda N Shima N Nakagawa Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci USA 95 1998 3597 3602
3. D.L Lacey E Timms H.L Tan Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176
4. Y.Y Kong H Yoshida I Sarosi OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 1999 315 323
5. W.C Dougall M Glaccum K Charrier RANK is essential for osteoclast and lymph node development Genes Dev 13 1999 2412 2424
6. W.S Simonet D.L Lacey C.R Dunstan Osteoprotegerin a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
7. A Mizuno N Amizuka K Irie Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin Biochem Biophys Res Commun 247 1998 610 615
8. E Corey E.W Arfman A.Y Liu Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow Clin Chem 43 1997 443 452
9. T.J Yun P.M Chaudhary G.L Shu OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40 J Immunol 161 1998 6113 6121
10. K.S Koeneman F Yeung L.W Chung Osteomimetic properties of prostate cancer cells a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment Prostate 39 1999 246 261
11. O.S Nielsen A.J Munro I.F Tannock Bone metastases pathophysiology and management policy J Clin Oncol 9 1991 509 524
12. H Takai M Kanematsu K Yano Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells J Biol Chem 273 1998 27091 27096
13. L.C Hofbauer D.L Lacey C.R Dunstan Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells Bone 25 1999 255 259
14. J.G Emery P McDonnell M.B Burke Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL J Biol Chem 273 1998 14363 14367
15. L Lum B.R Wong R Josien Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival J Biol Chem 274 1999 13613 13618
16. P Honore N.M Luger M.A Sabino Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord Nat Med 6 2000 521 528